All Type of News
Diovan takes on Norvasc
Novartis Korea is enjoying brisk sales of its antihypertensive agent, Diovan (valsartan).
Sales of Novartis Korea's antihypertensive medicine are estimated at 78 billion won last year, making it one of the top-sell...
Suspicions raised over sudden cancellation of drug price probe
Despite the government's determination to investigate unfair business transaction of 14 drug makers and 8 wholesalers through the alleged price fixing, the news that the recently formed task force team cancelled its i...
Korea's ethical sales top 7.3 trillion won in 2007
The domestic ethical market for outpatients came to 7.3 trillion won last year, up 11.2 percent over the previous year as major pharmaceutical firms, including Dong-A Pharm and Yuhan Corp., increased their share of th...
Boryung to step up presence in domestic market
Boryung plans to solidify its market position in the domestic market by launching new drug and promoting its flagship products including Gelfos-M and Cilalong, according to a senior official who announced its manageme...
Ilyang Pharm CEO steps down
Ilyang Pharm announced on January 17 that its chief executive officer Yoo Tai-sook resigned.
Under Yoo's resignation, Ilyang Chairman Chung Do-Un, a joint CEO, will be solely responsible for the company management....
Korean biotechnology industry to expand 20% by 2020
Korea's biotechnology industry is expected to grow 19 percent by 2020 on an annual basis, the Korea Development Bank said recently.
According to the bank, Korea's biotechnology industry on an average has been growi...
Dispute over deposit designation system subsides
Discord over the deposit designation system, which has been promoted by the Korea Pharmaceutical Manufacturers Association to support scientific events has reportedly subsided as the Fair Trade Commission finally agre...
Kukje to launch Novasc generic
Kukje Pharm says it plans to market amlodipine 5 mg as Pfizer's Novasc generic drug from January 21, despite the current patent lawsuit over amlodipne between Pfizer Korea and Ahngook Pharm.
We decided to launch am...
KFDA approves 9 clinical trials
The Korea Food and Drug Administration said it gave a green light for clinical trials for nine drugs, including Daehwa's anticancer agent DHP107 (paclitaxel) and GlaxoSmithKline's Tykerb (lapatinib).
Tykerb, an exp...
Establishment of new GMP training center eyed
The government says the establishment of new GMP (good manufacturing practices) center is being promoted with an aim to nurture local GMP professionals, instead of utilizing the existing drug manufacturer's facility a...
